A Patient Preference Study Comparing Two Extended-Release Morphine Sulfate Formulations (Once-Daily Kadian versus Twice-Daily MS Contin) for Cancer Pain

By Kerr R.O.  

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 25-32

Adis International

Access to resources Recommend Favorite

Meta-analysis of once-daily and twice-daily lopinavir/ritonavir combined with NRTIs in HIV-1-infected, antiretroviral-naive patients

By van Wyk Jean   Qaqish Roula   Hollar Kimberly   White Kelly   D’’Amico Ronald   Norton Michael   Chiu Yi-Lin   King Martin  

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 103-113

Future Medicine

Access to resources Recommend Favorite

Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: A randomized, double‐blind, parallel‐group, multicenter study

By  

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3635-3644

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Quinapril 40mg Once Daily as Monotherapy for Patients with Poorly Controlled Hypertension: The EUREKA Study

By Pueyo C.   Diaz C.   Sol J.   Masramon X.   Hernandez G.  

Clinical Drug Investigation, Vol. 20, Iss. 2, 2000-08 ,pp. : 81-88

Adis International

Access to resources Recommend Favorite

Once-daily carmoterol challenges twice-daily formoterol in asthma

By  

Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite